Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients
Author(s) -
Ann E. Woolley,
Steve K. Singh,
Hilary J. Goldberg,
Hari R. Mallidi,
Michael M. Givertz,
Mandeep R. Mehra,
Antonio Coppolino,
Amanda E. Kusztos,
Megan Johnson,
Kaiwen Chen,
Esther Arbona Haddad,
John Fanikos,
David P. Harrington,
Phillip C. Camp,
Lindsey R. Baden
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1812406
Subject(s) - lung , virology , medicine , intensive care medicine , cardiology
Hearts and lungs from donors with hepatitis C viremia are typically not transplanted. The advent of direct-acting antiviral agents to treat hepatitis C virus (HCV) infection has raised the possibility of substantially increasing the donor organ pool by enabling the transplantation of hearts and lungs from HCV-infected donors into recipients who do not have HCV infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom